BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,346,296 | -25.6% | 62,170 | -10.2% | 0.06% | -25.6% |
| Q2 2023 | $3,154,802 | +5.5% | 69,245 | -6.1% | 0.08% | -4.7% |
| Q1 2023 | $2,991,097 | -66.3% | 73,745 | -57.7% | 0.09% | -33.8% |
| Q4 2022 | $8,888,556 | +68.0% | 174,388 | +77.5% | 0.13% | -24.0% |
| Q3 2022 | $5,290,000 | -20.1% | 98,223 | -4.7% | 0.17% | -13.6% |
| Q2 2022 | $6,618,000 | -30.2% | 103,033 | -15.7% | 0.20% | -16.5% |
| Q1 2022 | $9,480,000 | -24.2% | 122,263 | -16.1% | 0.24% | -20.5% |
| Q4 2021 | $12,504,000 | -51.1% | 145,665 | -54.2% | 0.30% | -55.1% |
| Q3 2021 | $25,590,000 | -3.5% | 318,166 | -3.4% | 0.66% | -5.8% |
| Q2 2021 | $26,515,000 | +2.4% | 329,377 | +7.2% | 0.70% | -11.9% |
| Q1 2021 | $25,905,000 | -6.7% | 307,152 | -11.2% | 0.80% | -13.2% |
| Q4 2020 | $27,758,000 | -7.1% | 345,943 | -6.9% | 0.92% | -16.0% |
| Q3 2020 | $29,867,000 | -7.4% | 371,391 | -0.9% | 1.10% | -8.5% |
| Q2 2020 | $32,252,000 | +2.5% | 374,591 | -3.3% | 1.20% | -14.3% |
| Q1 2020 | $31,458,000 | -18.9% | 387,455 | -16.5% | 1.40% | +9.2% |
| Q4 2019 | $38,781,000 | -6.6% | 463,780 | -2.3% | 1.28% | -12.4% |
| Q3 2019 | $41,517,000 | +1.2% | 474,640 | -5.2% | 1.46% | +1.5% |
| Q2 2019 | $41,015,000 | -3.5% | 500,799 | -4.2% | 1.44% | -5.1% |
| Q1 2019 | $42,485,000 | +18.9% | 522,510 | -3.8% | 1.52% | +5.9% |
| Q4 2018 | $35,737,000 | -20.3% | 542,957 | -6.7% | 1.43% | +0.7% |
| Q3 2018 | $44,848,000 | -20.1% | 581,756 | -23.5% | 1.42% | -24.5% |
| Q2 2018 | $56,149,000 | +10.5% | 760,408 | -2.7% | 1.89% | +10.2% |
| Q1 2018 | $50,829,000 | -3.7% | 781,500 | -4.3% | 1.71% | -1.2% |
| Q4 2017 | $52,794,000 | -2.2% | 816,741 | -5.0% | 1.73% | -2.4% |
| Q3 2017 | $53,968,000 | -1.7% | 860,048 | -5.1% | 1.78% | -4.0% |
| Q2 2017 | $54,884,000 | +13.5% | 906,582 | -2.8% | 1.85% | +9.3% |
| Q1 2017 | $48,368,000 | +12.2% | 932,666 | -4.0% | 1.69% | +9.1% |
| Q4 2016 | $43,090,000 | -11.9% | 971,811 | -5.4% | 1.55% | -12.1% |
| Q3 2016 | $48,895,000 | -17.9% | 1,027,204 | -22.0% | 1.76% | -16.1% |
| Q2 2016 | $59,553,000 | +0.1% | 1,316,979 | -9.1% | 2.10% | +1.2% |
| Q1 2016 | $59,488,000 | +2.3% | 1,448,104 | -5.0% | 2.08% | +4.8% |
| Q4 2015 | $58,160,000 | -6.7% | 1,524,505 | -19.7% | 1.98% | +5.1% |
| Q3 2015 | $62,345,000 | -55.0% | 1,897,896 | -4.3% | 1.89% | -47.8% |
| Q2 2015 | $138,691,000 | -4.4% | 1,983,293 | -6.3% | 3.61% | -0.5% |
| Q1 2015 | $145,062,000 | -9.1% | 2,117,698 | -2.8% | 3.63% | -6.3% |
| Q4 2014 | $159,598,000 | -0.1% | 2,177,626 | -2.1% | 3.87% | +3.2% |
| Q3 2014 | $159,690,000 | -0.2% | 2,225,027 | +0.6% | 3.75% | +4.5% |
| Q2 2014 | $159,968,000 | -3.1% | 2,212,554 | -1.4% | 3.59% | -6.9% |
| Q1 2014 | $165,043,000 | +5.5% | 2,243,050 | -0.3% | 3.86% | +0.9% |
| Q4 2013 | $156,424,000 | +18.0% | 2,249,087 | +11.4% | 3.82% | +9.6% |
| Q3 2013 | $132,567,000 | -1.8% | 2,018,068 | +3.5% | 3.49% | -5.3% |
| Q2 2013 | $135,058,000 | – | 1,949,736 | – | 3.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |